Robert Burns
Stock Analyst at HC Wainwright & Co.
(4.14)
# 702
Out of 5,182 analysts
515
Total ratings
48.19%
Success rate
14.86%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRLD Prelude Therapeutics | Maintains: Buy | $5 → $8 | $4.38 | +82.65% | 18 | Apr 27, 2026 | |
| NRIX Nurix Therapeutics | Reiterates: Buy | $32 | $17.21 | +85.94% | 24 | Apr 27, 2026 | |
| BNTX BioNTech SE | Reiterates: Buy | $130 | $101.66 | +27.88% | 48 | Apr 27, 2026 | |
| RVMD Revolution Medicines | Reiterates: Buy | $169 | $146.16 | +15.63% | 23 | Apr 22, 2026 | |
| MOLN Molecular Partners AG | Reiterates: Buy | $13 | $4.28 | +203.74% | 4 | Apr 22, 2026 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $12 → $11 | $2.23 | +394.38% | 19 | Apr 16, 2026 | |
| TLX Telix Pharmaceuticals | Reiterates: Buy | $20 | $10.43 | +91.75% | 6 | Apr 13, 2026 | |
| REPL Replimune Group | Downgrades: Sell | n/a | $2.66 | - | 21 | Apr 13, 2026 | |
| CRBU Caribou Biosciences | Reiterates: Buy | $9 | $2.07 | +334.78% | 16 | Apr 7, 2026 | |
| ORIC ORIC Pharmaceuticals | Reiterates: Buy | $25 | $9.83 | +154.32% | 29 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $19.00 | +73.68% | 2 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $42 | $22.03 | +90.65% | 6 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $8.85 | +69.49% | 12 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $56 | $43.59 | +28.47% | 6 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $8 | $8.57 | -6.60% | 5 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $27 | $7.90 | +241.77% | 4 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $19 | $13.47 | +41.05% | 23 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $3.81 | +109.97% | 23 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $13 | $4.10 | +217.46% | 7 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $27 | $5.22 | +417.24% | 5 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $17 | $10.79 | +57.55% | 9 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $4.83 | +44.93% | 2 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $44 | $29.67 | +48.30% | 12 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $29 | $8.94 | +224.57% | 2 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $27 | $24.61 | +9.71% | 13 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $46 | $28.21 | +63.09% | 24 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $54 | $45.13 | +19.65% | 15 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.12 | +371.70% | 5 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.72 | +483.09% | 4 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $17 | $4.53 | +275.28% | 18 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $27 | $12.92 | +108.98% | 4 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $52 | $36.93 | +40.81% | 16 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $2 | $3.04 | -34.21% | 22 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $1.31 | +281.68% | 8 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $2.75 | +263.64% | 14 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.44 | +248.43% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $4.81 | - | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $12.85 | +1,456.42% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,320 → $240 | $0.22 | +109,239.41% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.27 | +55,342.62% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $4.22 | +160.97% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50,000 → $45,000 | $2.18 | +2,064,120.18% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $1.49 | +775.42% | 1 | Jan 7, 2021 |
Prelude Therapeutics
Apr 27, 2026
Maintains: Buy
Price Target: $5 → $8
Current: $4.38
Upside: +82.65%
Nurix Therapeutics
Apr 27, 2026
Reiterates: Buy
Price Target: $32
Current: $17.21
Upside: +85.94%
BioNTech SE
Apr 27, 2026
Reiterates: Buy
Price Target: $130
Current: $101.66
Upside: +27.88%
Revolution Medicines
Apr 22, 2026
Reiterates: Buy
Price Target: $169
Current: $146.16
Upside: +15.63%
Molecular Partners AG
Apr 22, 2026
Reiterates: Buy
Price Target: $13
Current: $4.28
Upside: +203.74%
Allogene Therapeutics
Apr 16, 2026
Maintains: Buy
Price Target: $12 → $11
Current: $2.23
Upside: +394.38%
Telix Pharmaceuticals
Apr 13, 2026
Reiterates: Buy
Price Target: $20
Current: $10.43
Upside: +91.75%
Replimune Group
Apr 13, 2026
Downgrades: Sell
Price Target: n/a
Current: $2.66
Upside: -
Caribou Biosciences
Apr 7, 2026
Reiterates: Buy
Price Target: $9
Current: $2.07
Upside: +334.78%
ORIC Pharmaceuticals
Apr 2, 2026
Reiterates: Buy
Price Target: $25
Current: $9.83
Upside: +154.32%
Mar 31, 2026
Maintains: Buy
Price Target: $30 → $33
Current: $19.00
Upside: +73.68%
Mar 31, 2026
Maintains: Buy
Price Target: $40 → $42
Current: $22.03
Upside: +90.65%
Mar 30, 2026
Reiterates: Buy
Price Target: $15
Current: $8.85
Upside: +69.49%
Mar 26, 2026
Maintains: Buy
Price Target: $48 → $56
Current: $43.59
Upside: +28.47%
Mar 25, 2026
Maintains: Buy
Price Target: $15 → $8
Current: $8.57
Upside: -6.60%
Mar 23, 2026
Maintains: Buy
Price Target: $50 → $27
Current: $7.90
Upside: +241.77%
Mar 23, 2026
Maintains: Buy
Price Target: $14 → $19
Current: $13.47
Upside: +41.05%
Mar 23, 2026
Maintains: Buy
Price Target: $7 → $8
Current: $3.81
Upside: +109.97%
Mar 23, 2026
Maintains: Buy
Price Target: $12 → $13
Current: $4.10
Upside: +217.46%
Mar 16, 2026
Maintains: Buy
Price Target: $34 → $27
Current: $5.22
Upside: +417.24%
Mar 13, 2026
Maintains: Buy
Price Target: $13 → $17
Current: $10.79
Upside: +57.55%
Mar 13, 2026
Reiterates: Buy
Price Target: $7
Current: $4.83
Upside: +44.93%
Mar 6, 2026
Maintains: Buy
Price Target: $42 → $44
Current: $29.67
Upside: +48.30%
Mar 6, 2026
Maintains: Buy
Price Target: $27 → $29
Current: $8.94
Upside: +224.57%
Mar 6, 2026
Maintains: Buy
Price Target: $13 → $27
Current: $24.61
Upside: +9.71%
Mar 6, 2026
Maintains: Buy
Price Target: $32 → $46
Current: $28.21
Upside: +63.09%
Feb 12, 2026
Maintains: Buy
Price Target: $52 → $54
Current: $45.13
Upside: +19.65%
Feb 3, 2026
Reiterates: Buy
Price Target: $10
Current: $2.12
Upside: +371.70%
Jan 28, 2026
Reiterates: Buy
Price Target: $10
Current: $1.72
Upside: +483.09%
Jan 12, 2026
Maintains: Buy
Price Target: $18 → $17
Current: $4.53
Upside: +275.28%
Jan 8, 2026
Maintains: Buy
Price Target: $26 → $27
Current: $12.92
Upside: +108.98%
Jan 6, 2026
Maintains: Buy
Price Target: $50 → $52
Current: $36.93
Upside: +40.81%
Nov 3, 2025
Reiterates: Neutral
Price Target: $2
Current: $3.04
Upside: -34.21%
Oct 31, 2025
Upgrades: Buy
Price Target: $5
Current: $1.31
Upside: +281.68%
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $2.75
Upside: +263.64%
Mar 20, 2025
Reiterates: Buy
Price Target: $5
Current: $1.44
Upside: +248.43%
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $4.81
Upside: -
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $12.85
Upside: +1,456.42%
Mar 21, 2024
Maintains: Buy
Price Target: $1,320 → $240
Current: $0.22
Upside: +109,239.41%
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $0.27
Upside: +55,342.62%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $4.22
Upside: +160.97%
Nov 24, 2021
Maintains: Buy
Price Target: $50,000 → $45,000
Current: $2.18
Upside: +2,064,120.18%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $1.49
Upside: +775.42%